| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Day One Biopharmaceuticals, Inc. (DAWN) has 13 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. DAWN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 237.0K | $5.10M | - | |
| CFO | 126.0K | $2.71M | - | |
| Other | 114.0K | $2.45M | - | |
| Other | 74.0K | $1.59M | - | |
| Other | 70.0K | $1.51M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2021 | Atlas Venture Fund Xi, L.P.53 | 10% Owner | Buy | 500,000 | $16.00 | $8,000,000.00 | New | +28.7% | -69.2% | |
| Jun 1, 2021 | Grant Papanek Julie78 | Director | Buy | 13,000 | $16.00 | $208,000.00 | +0.1% | +28.7% | -69.2% |